Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Terhi Jokilehto
EGFRgene Copy Number Predicts Response to Anti-Egfr Treatment inRASwild Type andRAS/BRAF/PIK3CAwild Type Metastatic Colorectal Cancer
International Journal of Cancer
Cancer Research
Oncology
Protein Phosphatase 2A (PP2A) Inhibitor CIP2A Indicates Resistance to Radiotherapy in Rectal Cancer
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
EGFR Gene Copy Number Assessment From Areas With Highest EGFR Expression Predicts Response to Anti-Egfr Therapy in Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
HER2 Gene Copy Number Status May Influence Clinical Efficacy to Anti-Egfr Monoclonal Antibodies in Metastatic Colorectal Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
RAS and BRAF in Metastatic Colorectal Cancer Management
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
Molecular Determinants of Anti-Egfr Sensitivity and Resistance in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
EGFR Alterations and Response to Anti-Egfr Therapy: Is It a Matter of Gene Amplification or Gene Copy Number Gain?
British Journal of Cancer
Cancer Research
Oncology
